The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAegon Ord Regulatory News (0Q0Y)

Share Price Information for Aegon Ord (0Q0Y)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.894
Bid: 5.60
Ask: 6.188
Change: -0.023 (-0.39%)
Spread: 0.588 (10.50%)
Open: 5.886
High: 5.894
Low: 5.882
Prev. Close: 5.917
0Q0Y Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stock fraction final dividend 2011 AEGON at 1/33

8 Jun 2012 18:30

AEGON determines stock fraction final dividend 2011 at 1/33

AEGON shareholders approved the proposed 2011 final dividend at the Annual General Meeting on May 16, 2012. Shareholders were given the choice between a final dividend in either cash or stock.

The cash dividend amounts to EUR 0.10 per common share and will be payable as of June 15, 2012.

Shareholders who elected a stock dividend will receive one new AEGON common share for every 33 common shares held. The stock fraction is based on AEGON's average share price as quoted on the Euronext Amsterdam Stock Exchange, calculated over the five trading days from June 4 up to and including June 8, 2012. The stock dividend and the cash dividend are approximately equal in value.

About AEGON

As an international life insurance, pensions and asset management company based in The Hague, AEGON has businesses in over twenty markets in the Americas, Europe and Asia. AEGON companies employ over 25,000 people and have nearly 47 million customers across the globe.

Key figures - EUR Q1 2012 Full year 2011 Underlying earnings 425 1.5 billionbefore tax million New life sales 445 1.8 billion million Gross deposits 11.0 32 billion billion Revenue-generating 437 424 billioninvestments billion (end of period) Contact informationMedia Relations:Greg Tucker+ 31 (0) 70 344 8956gcc-ir@aegon.comInvestor Relations:Willem van den Berg+ 31 (0) 70 344 8305ir@aegon.comwww.aegon.comForward-looking statements

The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to AEGON. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. AEGON undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

* Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; * Changes in the performance of financial markets, including emerging markets, such as with regard to: - The frequency and severity of defaults by issuers in AEGON's fixed income investment portfolios; and - The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities AEGON holds; - The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that AEGON holds; * Changes in the performance of AEGON's investment portfolio and decline in ratings of the company's counterparties; * Consequences of a potential (partial) break-up of the euro; * The frequency and severity of insured loss events; * Changes affecting mortality, morbidity, persistence and other factors that may impact the profitability of AEGON's insurance products; * Reinsurers to whom AEGON has ceded significant underwriting risks may fail to meet their obligations; * Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; * Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; * Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; * Changes in laws and regulations, particularly those affecting AEGON's operations, ability to hire and retain key personnel, the products the company sells, and the attractiveness of certain products to its consumers; * Regulatory changes relating to the insurance industry in the jurisdictions in which AEGON operates; * Changes in customer behavior and public opinion in general related to, among other things, the type of products also AEGON sells, including legal, regulatory or commercial necessity to meet changing customer expectations; * Acts of God, acts of terrorism, acts of war and pandemics; * Changes in the policies of central banks and/or governments; * Lowering of one or more of AEGON's debt ratings issued by recognized rating organizations and the adverse impact such action may have on the company's ability to raise capital and on its liquidity and financial condition; * Lowering of one or more of insurer financial strength ratings of AEGON's insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability of its insurance subsidiaries and liquidity; * The effect of the European Union's Solvency II requirements and other regulations in other jurisdictions affecting the capital AEGON is required to maintain; * Litigation or regulatory action that could require AEGON to pay significant damages or change the way the company does business; * As AEGON's operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt the company's business, damage its reputation and adversely affect its results of operations, financial condition and cash flows; * Customer responsiveness to both new products and distribution channels; * Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for AEGON's products; * Changes in accounting regulations and policies may affect AEGON's reported results and shareholder's equity; * The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including AEGON's ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; * Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt AEGON's business; and * AEGON's failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives.

Further details of potential risks and uncertainties affecting the company are described in the company's filings with NYSE Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Press release

June 8, 2012

XNYS
12
Date   Source Headline
29th Jun 20127:00 amPRNAEGON's listing on the London Stock Exchange cancelled
19th Jun 20127:00 amPRNAEGON defines path for capturing growth in core markets
8th Jun 20126:30 pmPRNStock fraction final dividend 2011 AEGON at 1/33
31st May 20127:00 amPRNAEGON accelerates improvements NL unit-linked policies
23rd May 20127:00 amPRNAEGON to cancel its listing on the LSE
16th May 20124:00 pmPRNSummary of Annual General Meeting of Shareholders
10th May 20127:00 amPRNQ1 2012 Results
10th May 20127:00 amPRNAEGON's 2011 total EV increased 10% to EUR 20.7 billion
12th Apr 20127:00 amPRNAEGON recategorizes reporting Asian operations
4th Apr 20127:00 amPRNAEGON N.V. publishes agenda AGM
23rd Mar 20123:15 pmPRNAEGON files Annual Report 2011
17th Feb 20127:00 amPRNAEGON UK CEO Adrian Grace appointed to Management Board
17th Feb 20127:00 amPRNAEGON maintains strong capital position
27th Jan 20127:00 amPRNAEGON into EUR 2 billion syndicated credit facility
25th Jan 20127:15 amPRNUSD 500 mln 8% non-cumulative subordinated notes
6th Dec 20117:00 amPRNAEGON to reaffirm targets at annual investor conference
24th Nov 20117:00 amPRNAEGON completes sale of Guardian in the UK
10th Nov 20117:00 amPRN3rd Quarter Results
29th Sep 20117:30 amPRNAEGON to Restructure Business in the Netherlands
16th Aug 20117:00 amPRNAEGON to Sell Closed UK Life Insurance Business Guardian
11th Aug 20117:00 amPRNQ2 2011 Results
10th Aug 20117:00 amPRNAEGON completes divestment of Transamerica Reinsurance
8th Aug 20117:00 amPRNMr Docters van Leeuwen steps down from Supervisory Board
15th Jun 20117:00 amPRNAEGON completes repayment to Dutch State
12th May 20115:25 pmPRNSummary of Annual General Meeting of Shareholders
12th May 20117:00 amPRNAEGON's 2010 Total Embedded Value Increased to EUR18.9bn
12th May 20117:00 amPRNAEGON announces Q1 net income of EUR 327 million
26th Apr 20117:00 amPRNAEGON to divest Transamerica Reinsurance to SCOR
14th Apr 20117:00 amPRNCompletes Sale of EUR1.5 bn `SAECURE 10' RMBS notes
31st Mar 20113:00 pmPRNAEGON’s 2010 Form 20-F and Annual Report available
31st Mar 20117:00 amPRNNominations EB and SB AEGON N.V.
16th Mar 20117:00 amPRNAEGON repurchased EUR750 mln core capital securities
8th Mar 20117:00 amPRNAEGON appoints Adrian Grace CEO AEGON UK
24th Feb 20113:50 pmPRNAEGON completes 10% equity issue
24th Feb 20117:00 amPRNAEGON to launch equity issue of 10%
24th Feb 20117:00 amPRNAEGON announces strong Q4 2010 results
16th Feb 20117:00 amPRNAEGON Supervisory Board Member Cecelia Kempler to Resign
16th Dec 201011:42 amPRNAEGON UK response to FSA notice re Scottish Equitable
8th Dec 20107:00 amPRNAEGON to detail progress in execution of strategy
2nd Dec 20107:00 amPRNAEGON to sharpen focus on core activities in US
27th Sep 20104:45 pmPRNAEGON completes sale of EUR 842 million RMBS notes
7th Sep 20107:00 amPRNAEGON appoints Global Head of Sustainability
31st Aug 20107:00 amPRNAEGON repays EUR 500 million of government support
17th Aug 20107:00 amPRNAEGON concludes approval process European Commission
12th Aug 20107:00 amPRNAEGON posts strong results for second quarter 2010
13th Jul 20107:00 amPRNMs Russell appointed CEO AEGON Asset Management business
8th Jul 20107:00 amPRNAEGON completes sale of EUR 1 billion RMBS notes
6th Jul 20107:00 amPRNAEGON appoints global head of human resources
22nd Jun 20107:00 amPRNStatement re Strategy
1st Jun 20107:00 amPRNAEGON appoints Clare Bousfield CFO in UK
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.